Summit Therapeutics plc (SMMT) PT Raised to $34 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Cory Kasimov raised the price target on Summit Therapeutics plc (NASDAQ: SMMT) to $34.00 (from $30.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
